Greg Sutherland

Tau isoform expression in frontotemporal dementia without tau deposition.

Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics?

Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?

The effects of chronic alcoholism on cell proliferation in the human brain.

Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?

Using autopsy brain tissue to study alcohol-related brain damage in the genomic age.

Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy.

Comorbidities, confounders, and the white matter transcriptome in chronic alcoholism.

Lack of reproducibility in re-evaluating associations between GCH1 polymorphisms and Parkinson's disease and isolated dystonia in an Australian case--control group.

Neuropathology of alcoholism.

Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.

The rise and fall of insulin signaling in Alzheimer's disease.

Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.

The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research.

The effects of chronic smoking on the pathology of alcohol-related brain damage.

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.

Epidemiological Approaches to Understanding the Link Between Type 2 Diabetes and Dementia.

Imaging mass spectrometry of frontal white matter lipid changes in human alcoholics.